-transparent.png){kind=logo}
The unesterified cholesterol content of plasma samples can be evaluated from the extent of inhibition of lucensomycin-induced hemolysis. The test measures, however, only the fraction of cholesterol which is available for interaction with lucensomycin, this availability being adversely affected by high phospholipid-cholesterol ratios.
Related Publications
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
December 1976,
Biochimica et biophysica acta,
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
March 1968,
Canadian journal of physiology and pharmacology,
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
March 1945,
The Journal of general physiology,
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
February 1956,
The Journal of clinical investigation,
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
January 1959,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
February 1959,
Acta chirurgica Scandinavica,
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
January 1995,
The American journal of pathology,
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
May 1989,
Nutrition reviews,
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
November 1966,
JAMA,
C Crifó, and
A Oratore, and
F Rossi Fanelli, and
C Cangiano, and
S Equizi, and
R Strom
March 1995,
The Journal of biological chemistry,
